Functional integration among 5-hydroxytryptamine receptor families in the control of female rat sexual behavior
- PMID: 9748522
- DOI: 10.1016/s0006-8993(98)00554-x
Functional integration among 5-hydroxytryptamine receptor families in the control of female rat sexual behavior
Abstract
Serotonin (5-HT) receptor interaction in the control of female rat lordosis behavior was examined. Ovariectomized rats, with bilateral implants in the ventromedial nucleus of the hypothalamus (VMN), were hormonally primed with 25 micrograms estradiol benzoate and 500 micrograms progesterone. Rats were infused with the 5-HT3 receptor antagonist, 3-tropanyl-indole-3 carbonylate (tropisetron; 500 ng), or were coinfused with the 5-HT3 receptor antagonist and the 5-HT2A/2C receptor agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI; 500, 1500, or 2000 ng). Additional ovariectomized, hormone-primed rats received bilateral VMN infusions with the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT; 200 ng), or were coinfused with the 5-HT1A receptor agonist and the 5-HT3 receptor agonist, m-chlorophenyl-biguanide (mCPBG; 250, 500, or 1000 ng). Lordosis behavior was observed prior to VMN infusion, during the infusion and for 30 consecutive minutes thereafter. Tropisetron reduced the lordosis to mount (L/M) ratio in every animal investigated but the decline was attenuated by coinfusion with DOI. Similarly, the L/M ratio declined following infusion with 8-OH-DPAT and the decline was dose-dependently reduced by coinfusion with mCPBG. Only the 5-HT3 receptor agonist altered the quality of the lordosis reflex. These studies provide evidence that the effects of 5-HT on female rat lordosis behavior involve the integrated activity of at least 3 different 5-HT receptor families.
Similar articles
-
5-HT3 receptors in the ventromedial nucleus of the hypothalamus and female sexual behavior.Brain Res. 1997 Sep 19;769(1):13-20. doi: 10.1016/s0006-8993(97)00670-7. Brain Res. 1997. PMID: 9374268
-
5-HT1A receptor antagonists and lordosis behavior.Neuropharmacology. 1996 Apr;35(4):489-95. doi: 10.1016/0028-3908(95)00196-4. Neuropharmacology. 1996. PMID: 8793912
-
Factors elevating cAMP attenuate the effects of 8-OH-DPAT on lordosis behavior.Pharmacol Biochem Behav. 2000 Jun;66(2):383-8. doi: 10.1016/s0091-3057(00)00179-9. Pharmacol Biochem Behav. 2000. PMID: 10880694
-
Female gonadal hormones, serotonin, and sexual receptivity.Brain Res Brain Res Rev. 2000 Sep;33(2-3):242-57. doi: 10.1016/s0165-0173(00)00032-1. Brain Res Brain Res Rev. 2000. PMID: 11011068 Review.
-
Pharmacology of serotonin and female sexual behavior.Pharmacol Biochem Behav. 2014 Jun;121:31-42. doi: 10.1016/j.pbb.2013.11.008. Epub 2013 Nov 15. Pharmacol Biochem Behav. 2014. PMID: 24239784 Free PMC article. Review.
Cited by
-
Comparison of female Fischer and Sprague-Dawley rats in the response to ketanserin.Pharmacol Biochem Behav. 2013 Dec;114-115:52-7. doi: 10.1016/j.pbb.2013.10.024. Epub 2013 Nov 4. Pharmacol Biochem Behav. 2013. PMID: 24201045 Free PMC article.
-
Targeting G protein coupled receptor-related pathways as emerging molecular therapies.Saudi Pharm J. 2015 Apr;23(2):115-29. doi: 10.1016/j.jsps.2013.07.007. Epub 2013 Aug 13. Saudi Pharm J. 2015. PMID: 25972730 Free PMC article. Review.
-
Daily male exposure attenuates estrous cycle disruption by fluoxetine.Behav Brain Res. 2008 May 16;189(1):83-91. doi: 10.1016/j.bbr.2007.12.011. Epub 2007 Dec 23. Behav Brain Res. 2008. PMID: 18243351 Free PMC article.
-
Transient inhibition and long-term facilitation of locomotion by phasic optogenetic activation of serotonin neurons.Elife. 2017 Feb 14;6:e20975. doi: 10.7554/eLife.20975. Elife. 2017. PMID: 28193320 Free PMC article.
-
Characteristics of binding of [3H]WAY100635 to rat hippocampal membranes.Neurochem Res. 2006 Sep;31(9):1135-40. doi: 10.1007/s11064-006-9135-6. Epub 2006 Aug 26. Neurochem Res. 2006. PMID: 16937076
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources